Category: Inside The Vault

All Podcast Categories
S3-E40.5 - From the Vault: Why Cirrhosis Matters In Clinical Trial Strategy

S3-E40.5 – From the Vault: Why Cirrhosis Matters In Clinical Trial Strategy

This episode discusses the unique role NASH cirrhosis studies can play in clinical trial design, particularly in the transition from biopsy as gold standard to a post-biopsy world. Stephen Harrison starts this conversation by discussing why we focus on NASH cirrhosis and goes on to review the recent presentation of results from the REVERSE study on obeticholic acid. Jörn Schattenberg and Mazen Noureddin add their perspectives to the conversation.

S3-E39.5 - From The Vault: Early, Accurate Patient Information Matters

S3-E39.5 – From The Vault: Early, Accurate Patient Information Matters

In this conversation from September 2021, Anthony Villiotti of NASH kNOWledge joins Louise Campbell and Roger Green to discuss his “biggest story of the summer:” two publications, on demonstrating that NASH prevalence and incidence may be far higher than we believe and another demonstrating how limited public knowledge about NASH is today.

S3-E38.5 - From the Vault: NAIL-NIT tackles NAS Score Challenges

S3-E38.5 – From the Vault: NAIL-NIT tackles NAS Score Challenges

From February of this year, Stephen Harrison and Mazen Noureddin join Jörn Schattenberg, Louise Campbell and Roger Green to discuss the formation of the new NAIL-NIT consortium, led by Stephen and Mazen. This conversation focuses on the specific challenges inherent in the NAS scores.

S3-E38.3 - From the Vault: Learning Fibrosis at Paris NASH

S3-E38.3 – From the Vault: Learning Fibrosis at Paris NASH

From September 2021, Stephen Harrison and Jörn Schattenberg lead the Surfers on a deep dive into the fibrosis section of the recent Paris NASH conference. The conversation focuses on fibrosis and the role of stellate cells in fibrogenesis.

S3-E38.1 - From the Vault: Why NASH Drug Trials Fail

S3-E38.1 – From the Vault: Why NASH Drug Trials Fail

Our 2nd anniversary look in the Vault starts with Jörn Schattenberg’s first episode as a featured guest, a 2020 episode reviewing his article on why NASH drug trials fail. One key focus was the proper design and use of Phase 2 trials.

Experience Nudge Learning!
Interested in a new way of learning?